TALKW - Talkspace, Inc. Stock Analysis | Stock Taper
Logo
Talkspace, Inc.

TALKW

Talkspace, Inc. NASDAQ
$0.02 -5.26% (-0.00)

Market Cap $2.98 M
52w High $0.05
52w Low $0.02
P/E 0
Volume 196.81K
Outstanding Shares 165.66M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $63M $23.09M $4.76M 7.56% $0.03 $5.94M
Q3-2025 $59.38M $22.55M $3.25M 5.47% $0.02 $4.61M
Q2-2025 $54.31M $25.18M $-541K -1% $-0 $253K
Q1-2025 $52.18M $24.37M $318K 0.61% $0 $1.09M
Q4-2024 $48.72M $20.96M $1.21M 2.49% $0.01 $1.39M

What's going well?

Revenue is growing steadily and margins are improving. The company is profitable, with operating and net income up sharply from last quarter. No debt and clean results make the financials look healthy.

What's concerning?

R&D spending jumped, which could pressure profits if it doesn't lead to future growth. The business still runs on modest margins, so any slip in cost control could hurt earnings.

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $92.59M $134.86M $17.85M $117.02M
Q3-2025 $91.61M $129.06M $19.95M $109.11M
Q2-2025 $102.77M $132.79M $19.84M $112.94M
Q1-2025 $108.35M $134.25M $20.83M $113.42M
Q4-2024 $117.81M $138.68M $21.28M $117.39M

What's financially strong about this company?

TALKW has no debt, lots of cash and investments, and more than enough assets to cover all bills. Its assets are mostly high-quality, with very little tied up in goodwill or intangibles.

What are the financial risks or weaknesses?

The company has a history of losses, shown by negative retained earnings. Growth in receivables could mean customers are paying a bit slower.

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $4.76M $5.38M $-11.18M $-502K $-6.3M $2.08M
Q3-2025 $3.25M $4.75M $-6.32M $-9.12M $-10.69M $1.9M
Q2-2025 $-253.44K $-351K $-2.37M $-3.02M $-5.74M $-2.85M
Q1-2025 $318K $-1.24M $-9.02M $-6.36M $-16.61M $-3.24M
Q4-2024 $1.21M $4.08M $-42.9M $-3.49M $-42.3M $2.41M

What's strong about this company's cash flow?

The company generates more cash from its business than it reports in profits, with operating cash flow rising to $5.38 million. Free cash flow is positive and improving, and the business is not reliant on debt or outside funding.

What are the cash flow concerns?

Cash on hand dropped by $6.30 million, mainly due to investments and working capital needs. Customers are paying slower and the company is paying suppliers faster, which could hurt cash flow if it continues.

Q4 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Talkspace, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Talkspace’s main strengths include strong revenue growth, a visible path toward sustainable profitability, and a debt‑free balance sheet. Its deep integration with insurers and employers creates high access to covered patients and recurring revenue streams that many direct‑to‑consumer peers lack. On top of that, the company has turned operating and free cash flow positive, suggesting the business model is maturing, while ongoing investment in AI and data‑driven care gives it a chance to stand out in a crowded telehealth landscape.

! Risks

Key risks revolve around the still‑fragile nature of its financial profile and the competitiveness of its market. The balance sheet has been weakened by years of accumulated losses and shrinking cash reserves, leaving less margin for error if growth slows or margins compress. Competition from other digital health platforms, changing payer behavior, regulatory shifts, and therapist supply constraints all pose structural challenges. There is also execution risk around AI initiatives and product expansion: if these projects do not deliver tangible value, they could consume resources without strengthening the moat.

Outlook

The overall outlook appears cautiously constructive: Talkspace is transitioning from an early‑stage, cash‑burning growth story to a more disciplined, cash‑generating healthcare platform with entrenched payer relationships and meaningful innovation efforts. If it can sustain revenue growth, maintain or expand operating margins, and translate its AI and partnership strategies into better outcomes and stickier relationships, its financial and competitive position could steadily improve. At the same time, the company’s history of losses, declining asset base, and exposure to a dynamic regulatory and competitive environment mean that future performance still carries a fair amount of uncertainty.